As we wrap up 2020 and look back at the year we’ve all endured, it’s important to highlight the places where humanity shone through the darkness. One such place is in our research community. While the people around the nation were forced into isolation by stay at home orders or self-imposed quarantine, our research community … Read more
Today, we’re excited to announce a major milestone – we’ve delivered 1,000,000 COVID-19 tests since we first launched our testing in late June. While we’ve been scaling rapidly since then, we’ve recently accelerated tremendously, with over half of these tests being delivered in just the past four weeks.
Neanderthal DNA may influence how severe a person’s symptoms to COVID-19 are.
Symptoms of COVID-19 may endure for months after infection, even in people who initially experienced mild illness. This is the conclusion put forth by a collaborative team of researchers from Helix, Renown Health, and the Desert Research Institute after analyzing survey data from more than 21,000 individuals, 233 of which report having tested positive for COVID-19.
In a recent study, researchers from an international consortium used genetic data alongside survey responses to gain insight into how our DNA may affect our vulnerability to the SARS-CoV-2 virus (the virus responsible for the COVID-19 pandemic).
Here, we describe how the use of COVID-19 screening and the combined use of screening results for surveillance can be an effective way to manage COVID-19 outbreaks under various conditions based on epidemiological modeling.
Weekly testing enables rapid suppression of outbreaks even with widespread community transmission. Control of outbreaks through social distancing and surveillance testing lead to further reductions in testing frequency.
Data from Helix’s research community is helping scientists around the world, including a recent finding published in the New England Journal of Medicine.
Our team of researchers are currently working through the data, but we have already found some interesting insights in our collection of survey responses, and we’ve contributed our findings to a worldwide research effort, consisting of renowned scientists from around the globe. These results, described below, highlight the power of population health studies and the impact of sharing information early and often.
Helix researchers, along with collaborators from Renown Health and UC San Diego, found that, relative to nasopharyngeal swabs, the sensitivity of saliva was approximately 30% lower in a community-based diagnostic cohort and 50% lower in a convalescent cohort